Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DPP-4
    (34)
  • Proteasome
    (24)
  • Autophagy
    (4)
  • Ferroptosis
    (4)
  • Apoptosis
    (3)
  • Reactive Oxygen Species
    (2)
  • AMPK
    (1)
  • Aminopeptidase
    (1)
  • Antibacterial
    (1)
  • Others
    (69)
Filter
Search Result
Results for "

dpp

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    160
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    8
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    4
    TargetMol | Dye_Reagents
  • Natural Products
    9
    TargetMol | Natural_Products
  • Recombinant Protein
    23
    TargetMol | Recombinant_Protein
  • Isotope Products
    7
    TargetMol | Isotope_Products
  • Antibody Products
    51
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    13
    TargetMol | Inhibitors_Agonists
DPP
T796082668267-47-6
DPP, a Platinum(IV) complex with a pterostilbene-derived axial ligand, inhibits the JAK2-STAT3 pathway in breast cancer (BC) cells, demonstrating antiproliferative activity. It activates caspase-3 and cleaved poly ADP-ribose polymerase, inducing apoptosis. Furthermore, DPP enhances the maturation and antigen presentation of dendritic cells and exhibits in vivo safety [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Linagliptin
BI 1356
T0191668270-12-0
Linagliptin (BI 1356) is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
  • $38
In Stock
Size
QTY
Vildagliptin
NVP-LAF 237, LAF237
T1502274901-16-5
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolite is excreted mainly via the urine.
  • $39
In Stock
Size
QTY
Trelagliptin succinate
SYR-472 succinate, SYR472
T22961029877-94-8
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Trelagliptin
SYR-472
T6237865759-25-7
Trelagliptin (SYR-472) is a highly specific, long-acting DPP-4 inhibitor.
  • $41
In Stock
Size
QTY
Anagliptin
SK-0403
T7133739366-20-2
Anagliptin (SK-0403) is a potent inhibitor of DPP-4 (IC50 of 3.8 nM) used in the treatment of type 2 diabetes mellitus.
  • $39
In Stock
Size
QTY
Retagliptin Phosphate
SP 2086
T127101256756-88-3
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Puromycin aminonucleoside
NSC 3056
T1668458-60-6
Puromycin aminonucleoside (NSC 3056) is an aminonucleoside antibiotic and a purine analog of puromycin. It can reversibly inhibit dipeptidyl peptidase and cytosolic alanine aminopeptidase, increase podocyte permeability by regulating ZO-1 in an oxidative stress-dependent manner, induce apoptosis, and promote the secretion of migrasomes. It is commonly used to induce nephrotic syndrome models in research.
  • $39
In Stock
Size
QTY
Talabostat mesylate
Val-boroPro, PT100
T4042150080-09-4
Talabostat mesylate (PT100) is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation protein. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony-stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis.
  • $50
In Stock
Size
QTY
UAMC00039 dihydrochloride
UAMC 00039 dihydrochloride
T4467697797-51-6
UAMC00039 dihydrochloride is a potent, reversible, and competitive inhibitor of dipeptidyl peptidase II, with an IC50 of 0.48 nM.
  • $37
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Azaleatin
TN1418529-51-1
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity studies.
  • $105
In Stock
Size
QTY
Brensocatib
INS 1007, AZD7986
TQ00381802148-05-5
Brensocatib (AZD7986) is a Dipeptidyl peptidase 1 (DPP1) inhibitor (pIC50s: 6.85, 7.7, 7.6, 7.8, and 7.8 in human, rat, mouse, rabbit, and dog, respectively).
  • $52
In Stock
Size
QTY
DPP-IV-IN-1
T10082625110-37-4In house
DPP-IV-IN-1 is an effective inhibitor of dipeptidyl peptidase IV (DPP-IV), a serine protease (IC50: 4.6 nM).
  • $1,520
3-6 months
Size
QTY
DPP-IV-IN-2
H-Lys(4-nitro-Z)-pyrrolidide
T11526136259-18-2
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8 9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
  • $34
In Stock
Size
QTY
DPP-4-IN-12
T200529
DPP-4-IN-12 (compound 46) is an effective DPP-4 inhibitor with an IC50 of 2 nM, utilized in the study of type 2 diabetes.
  • Inquiry Price
Size
QTY
DPP-21
T2005602924883-83-8
DPP-21 is an inhibitor of microtubule protein polymerization (IC50: 2.4 μM). It exhibits antiproliferative activity against various cancer cell lines, with IC50 values of 0.38 nM (HCT116), 11.69 nM (B16), 5.37 nM (HeLa), 9.53 nM (MCF7), 8.94 nM (H23), and 9.37 nM (HepG2). DPP-21 induces cell cycle arrest at the G2 M phase of mitosis and subsequently triggers apoptosis in tumor cells by decreasing Bcl-2 while increasing pro-apoptotic protein Bax levels.
  • $1,520
4-6 weeks
Size
QTY
DPP-4-IN-13
T201436
DPP-4-IN-13 (compound 9i) is a competitive inhibitor of DPP4, exhibiting an IC50 of 9.25 μM, making it suitable for research in type 2 diabetes.
  • Inquiry Price
10-14 weeks
Size
QTY
DPP-4-IN-14
T204855
DPP-4-IN-14 (compound 30) is an inhibitor of DPP-4, with an IC50 value of 12.82 nM.
  • Inquiry Price
Size
QTY
DPP-4-IN-15
T2050363035300-36-5
DPP-4-IN-15 (Compound 22) is a non-competitive inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 value of 8.24 μM.
  • Inquiry Price
10-14 weeks
Size
QTY
5,15-DPP
T2150122112-89-6
5,15-Diphenylporphyrin (5,15-DPP) is a selective STAT3-SH2 antagonist with IC50 values of 0.28 μM for STAT3 and 10 μM for STAT1 [1].
  • $38
7-10 days
Size
QTY
NVP DPP 728 dihydrochloride
T21691247016-69-9
NVP-DPP728 is a potent, reversible, nitrile-dependent inhibitor of dipeptidyl peptidase IV (DPP-IV) with an inhibition constant (K i) of 11 nM for human DPP-IV amidolytic activity. By inhibiting the degradation of glucagon-like peptide-1 (GLP-1), NVP-DPP728 enhances insulin release following glucose intake, making it useful for diabetes research [1].
  • $1,520
6-8 weeks
Size
QTY
DPP-4-PIOL
DPP4PIOL
T24016439944-69-1
DPP-4-PIOL is an antagonist of GABAA. In dentate gyrus granule cells, it acts by selectively antagonizing tonic over phasic GABAergic currents.
  • $1,520
6-8 weeks
Size
QTY
DPP-4-IN-2
T610182133900-95-3
DPP-4-IN-2 (compound b2) is a structural analog of Alogliptin and a potent dipeptidyl peptidase 4 (DPP-4) inhibitor with an IC50 value of 79 nM [1], suitable for diabetes research.
  • $1,520
6-8 weeks
Size
QTY
DPP-4 inhibitor 3
T614142402735-14-0
Compound 5a, also known as DPP-4 inhibitor 3, is a powerful dipeptidyl peptidase IV (DPP-IV) inhibitor, demonstrating an IC50 value of 0.75 nM. It exhibits outstanding antioxidant and insulinotropic activity [1].
  • $1,520
6-8 weeks
Size
QTY